Beneficial effects of lidocaine and disopyramide on oxygen-deficiency-induced contractile failure and metabolic disturbance in isolated rabbit hearts. 1989

S Takeo, and K Tanonaka, and K Shimizu, and K Hirai, and K Miyake, and R Minematsu
Department of Physiology and Pharmacology, Faculty of Pharmaceutical Sciences, Fukuyama University, Japan.

The purpose of the present study was to determine whether antiarrhythmic agents, lidocaine and disopyramide, which reveal a membrane stabilizing action, may exert a beneficial effect on posthypoxic recovery of cardiac function and metabolism. Rabbit hearts were perfused for 20 min under hypoxic conditions, followed by 45-min reoxygenation. Hypoxic insults induced cessation of cardiac contractile force, rise in resting tension, depletion of myocardial high-energy phosphates, accumulation of tissue calcium and release of creatine kinase and ATP metabolites such as adenosine, inosine and hypoxanthine. These alterations were not returned to the initial levels upon reoxygenation. Administration of either 69 microM lidocaine or 55 microM disopyramide after the onset of oxygen deficiency (between 8th and 20th min of the hypoxia) resulted in a significant suppression of hypoxia-induced rise in resting tension, tissue calcium accumulation and release of creatine kinase and ATP metabolites, whereas hypoxia-induced decline in cardiac contractile force and depletion of myocardial high-energy phosphates were not affected by the treatment. The latter two variables were improved markedly during 45-min reoxygenation when the heart had been treated with the agents. The improvement was accompanied by a suppression of the release of creatine kinase and ATP metabolites and the tissue calcium accumulation. The results suggest that lidocaine and disopyramide are beneficial for posthypoxic recovery of cardiac function and metabolism.

UI MeSH Term Description Entries
D008012 Lidocaine A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE. Lignocaine,2-(Diethylamino)-N-(2,6-Dimethylphenyl)Acetamide,2-2EtN-2MePhAcN,Dalcaine,Lidocaine Carbonate,Lidocaine Carbonate (2:1),Lidocaine Hydrocarbonate,Lidocaine Hydrochloride,Lidocaine Monoacetate,Lidocaine Monohydrochloride,Lidocaine Monohydrochloride, Monohydrate,Lidocaine Sulfate (1:1),Octocaine,Xylesthesin,Xylocaine,Xylocitin,Xyloneural
D008297 Male Males
D009200 Myocardial Contraction Contractile activity of the MYOCARDIUM. Heart Contractility,Inotropism, Cardiac,Cardiac Inotropism,Cardiac Inotropisms,Contractilities, Heart,Contractility, Heart,Contraction, Myocardial,Contractions, Myocardial,Heart Contractilities,Inotropisms, Cardiac,Myocardial Contractions
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D010100 Oxygen An element with atomic symbol O, atomic number 8, and atomic weight [15.99903; 15.99977]. It is the most abundant element on earth and essential for respiration. Dioxygen,Oxygen-16,Oxygen 16
D010725 Phosphocreatine An endogenous substance found mainly in skeletal muscle of vertebrates. It has been tried in the treatment of cardiac disorders and has been added to cardioplegic solutions. (Reynolds JEF(Ed): Martindale: The Extra Pharmacopoeia (electronic version). Micromedex, Inc, Englewood, CO, 1996) Creatine Phosphate,Neoton,Phosphocreatine, Disodium Salt,Phosphorylcreatine,Disodium Salt Phosphocreatine,Phosphate, Creatine
D011817 Rabbits A burrowing plant-eating mammal with hind limbs that are longer than its fore limbs. It belongs to the family Leporidae of the order Lagomorpha, and in contrast to hares, possesses 22 instead of 24 pairs of chromosomes. Belgian Hare,New Zealand Rabbit,New Zealand Rabbits,New Zealand White Rabbit,Rabbit,Rabbit, Domestic,Chinchilla Rabbits,NZW Rabbits,New Zealand White Rabbits,Oryctolagus cuniculus,Chinchilla Rabbit,Domestic Rabbit,Domestic Rabbits,Hare, Belgian,NZW Rabbit,Rabbit, Chinchilla,Rabbit, NZW,Rabbit, New Zealand,Rabbits, Chinchilla,Rabbits, Domestic,Rabbits, NZW,Rabbits, New Zealand,Zealand Rabbit, New,Zealand Rabbits, New,cuniculus, Oryctolagus
D001834 Body Water Fluids composed mainly of water found within the body. Water, Body
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D002463 Cell Membrane Permeability A quality of cell membranes which permits the passage of solvents and solutes into and out of cells. Permeability, Cell Membrane

Related Publications

S Takeo, and K Tanonaka, and K Shimizu, and K Hirai, and K Miyake, and R Minematsu
December 1991, Journal of cardiovascular pharmacology,
S Takeo, and K Tanonaka, and K Shimizu, and K Hirai, and K Miyake, and R Minematsu
January 1989, Archives internationales de pharmacodynamie et de therapie,
S Takeo, and K Tanonaka, and K Shimizu, and K Hirai, and K Miyake, and R Minematsu
August 1992, The Journal of physiology,
S Takeo, and K Tanonaka, and K Shimizu, and K Hirai, and K Miyake, and R Minematsu
January 1988, Cardiovascular drugs and therapy,
S Takeo, and K Tanonaka, and K Shimizu, and K Hirai, and K Miyake, and R Minematsu
January 1980, Journal of cardiovascular pharmacology,
S Takeo, and K Tanonaka, and K Shimizu, and K Hirai, and K Miyake, and R Minematsu
October 1994, The American journal of physiology,
S Takeo, and K Tanonaka, and K Shimizu, and K Hirai, and K Miyake, and R Minematsu
January 1987, General pharmacology,
S Takeo, and K Tanonaka, and K Shimizu, and K Hirai, and K Miyake, and R Minematsu
November 1981, Canadian journal of physiology and pharmacology,
S Takeo, and K Tanonaka, and K Shimizu, and K Hirai, and K Miyake, and R Minematsu
November 2000, Pharmacological research,
Copied contents to your clipboard!